Biotechnology platforms and systems, including gene editing, cell therapy, and synthetic biology, enable groundbreaking treatments for conditions such as genetic disorders, cancer, and autoimmune diseases. Using innovative technologies to advance diagnostics and therapeutics is at the heart of Perdigó’s mission.
New biotechnology developers face technical challenges such as ensuring precise genetic modifications, achieving high efficiency in cell therapy production, and maintaining the viability and functionality of engineered cells. Additionally, integrating advanced bioinformatics tools and scaling these technologies to meet clinical and commercial demands present significant complexities. Regulatory compliance and navigating the evolving landscape of global health standards are also critical.
Emerging trends such as personalised medicine and regenerative therapies are reshaping the biotechnology market. Meanwhile, the rise of connected biotechnologies, which leverage data analytics and cloud computing, holds promise for more proactive and informed healthcare decisions, despite the barriers raised by data security and interoperability.
